Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 6 Esophageal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Nasopharyngeal Carcinoma 5 Lung Neoplasms 5 Nasopharyngeal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Breast Neoplasms 3 Neoplasms, Germ Cell and Embryonal 2 Head and Neck Neoplasms 2 Gallbladder Neoplasms 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Recurrence 1 Ovarian Neoplasms 1 Oesophagogastric Cancer 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Locally Advanced Cervical Carcinoma 1 Locally Advanced Cervical Cancer 1 Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer 1 Gastro-enteropancreatic neuroendocrine tumor 1 Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1 Endometrial Neoplasms 1 EGFR Positive Non-small Cell Lung Cancer 1

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Oesophagogastric Cancer × Cisplatin × Clear all

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡